V. Andryushchenko1, N. Kurdil2, B. Sheiman2, O. Ivashchenko3
1CNE "Kyiv City Clinical Hospital of Emergency Medical Care", Kyiv, Ukraine
2L.I. Medved’s Research Center of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Enterprise), Kyiv, Ukraine
3Shupyk National University of Health Care of Ukraine, Kyiv, Ukraine
Abstract. In Ukraine, parenteral ozone therapy has been successfully used for many years in the treatment of injuries, poisonings, infectious and non-infectious diseases. Clinical evaluation of the effectiveness of ozone therapy is carried out by doctors based on various approaches and using a wide range of biomarkers.
Aim. Analysis of the results of the practical use of parenteral ozone therapy and determination of parameters of its clinical effectiveness in the treatment of patients in the intensive care unit.
Materials and Methods. Summarized results of treatment of 144 patients with poisoning, injuries, infectious and somatic diseases, aged 18–72 years, women ‒ 84 (58.3%), men ‒ 60 (41.7%), who underwent a course of parenteral ozone therapy in 2017-2021 in the CNE Kyiv City Clinical Hospital of Emergency Medical Care and ozone therapy rooms of private clinics. Parenteral ozonation of blood was carried out with the help of devices of the "Bozon-N-plus" series following the methodology approved by the Ministry of Health of Ukraine ("Methods of ozone therapy", 2001). The methods of systematic, comparative and statistical analysis were used.
Results. All patients were divided into 5 clinical groups based on the nature of their disease: the first group ‒ patients with acute poisoning by substances of suffocating hemotoxic effect; the second group ‒ patients with acute infectious diseases; the third group ‒ patients with chronic non-infectious diseases; the fourth group ‒ patients with purulent wounds; the fifth group ‒ patients with drug addiction. Criteria for evaluating the effectiveness of ozone therapy were used for each clinical group. A total of 1423 medical procedures using ozone were performed. The average course of treatment consisted of 3 to 10 procedures. Among them, 313 procedures of intravenous infusion of ozonated physiological solution (200 ml, ozone dose ‒ 0.48 mg, procedures were performed daily or every other day) were performed. 1110 procedures of intravenous infusion of ozonated autologous blood (200 or ‒ 400 ml of autologous blood, ozone dose ‒ 1.8 or 3.6 mg) were performed. The beginning of the course of autohemotherapy was preceded by a session of intravenous administration of ozonated physiological solution (the first procedure), after which the course of autohemotherapy began, with a frequency of 2-3 times a week. Conclusions. The clinical effectiveness of ozone therapy has been confirmed through a complex dynamic assessment of the patient's condition, which involves the use of subjective assessments (well-being, mood, duration of sleep, severity of pain syndrome, etc.) and objective parameters of the patient (clinical, functional, laboratory indicators, specific biomarkers).
Keywords: chemical poisoning, ozone therapy, blood ozonation.
СПИСОК ВИКОРИСТАНИХ ДЖЕРЕЛ / REFERENCES
1. Ukrainian association of ozone therapists and manufacturers of medical equipment. Electronic resource. URL: http://www.medozone.com.ua.
2. All-Ukrainian association of ozone therapists and producers of ozone therapy equipment. Electronic resource. URL: http://ozonetherapy.com.ua.
3. Methods of using ozone in medicine: Method. Recommendations // Ministry of Health of Ukraine, Ukrmedpatentinform, Odesa State Medical University; All-Ukrainian association of ozone therapists and manufacturers of medical equipment for ozone therapy; Members: I.P. Shmakova, E.I. Nazarov, E.V. Yakymenko, A.E. Polyakov, S.F. Honcharuk, A.N. Ivanov, A.V. Artemenko, Yu.V. Prokopchuk. , T.M. Barhotkina, Yu.Y. Brezytsky, V.Y. Sidorov, S.V. Yanko, A.A. Shapovalova, A.G. Solodenko, S.N. Kolomiets, L.V. Honcharuk, Rozhkov V.S., Kasyanenko A.V., Rozhkova E.O. - Kyiv, 2004. - 46 p. [in russian].
4. Tondiy L.D., Ganichev V.V. Methodical recommendations – Methods of ozone therapy. - Kharkiv, 2001. - 68 p. [in russian].
5. Malakhov V.A., Ganychev V.V., Pasyura I.N. Methodological recommendations - Application of ozone therapy in neurology. - Kharkiv, 2007. - 29 p. [in russian].
6. Hryshchenko V.Y., Ganychev V.V., Zinchenko V.D., Lupoyad V.S., Lupoyad K.V. Methodological recommendations - Application of ozone therapy in obstetrics and gynecology. - Kharkiv, 2005. - 28 p. [in russian].
7. Fistal E.Ya., Ganychev V.V., Nosenko V.M., Makienko V.V. Methodical recommendations - Application of ozone therapy in the complex treatment of burns. - Donetsk, 2005. - 19 p.m. [in russian].
8. Tondiy L.D., Vasilyeva-Linetskaya L.Ya. - Recommended standards of sanatorium treatment. Addendum - Classification of natural and preformed physical healing factors, including ozone therapy - Kharkiv, 2003. - 72 p. [in russian].
9. Ozone and ozonation: Monograph / Chekman I.S., Syrovaya A.O., Makarov V.A., Makarov V.V., Lapshin V.V., Shapoval E.V. / - X: "Digital printing house No. 1", - 2013 - 144 p. [in russian].
10. Tondiy L.D., Ganychev V.V., Kozin Yu.I. Basic principles and methods of ozone therapy in medicine. Educational manual. – Kharkiv: Kharkiv Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine. Ukrainian association of ozone therapists and manufacturers of medical equipment. Institute of ozone therapy and medical equipment, 2001. – 104 p. [in russian].
11.Swanson TJ, Chapman J. Ozone Toxicity. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2019 Jan-.2019 Jan 20. URL: https://pubmed.ncbi.nlm.nih.gov/28613502/
12. Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009 Jul;29(4):646-82. DOI: 10.1002/med.20150.
13. Di Mauro R, Cantarella G, Bernardini R, Di Rosa M, Barbagallo I, Distefano A, Longhitano L, Vicario N, Nicolosi D, Lazzarino G, Tibullo D, Gulino ME, Spampinato M, Avola R, Li Volti G. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int J Mol Sci. 2019 Feb 1;20(3). pii: E634. DOI: 10.3390/ijms20030634.
14. Bocci V. Ozone. A new medical drug / V. Bocc. — Dordrecht, The Netherlands: Springer, 2011. — 240 p.
15. Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017 Oct 17;7(3):212-219. DOI: 10.4103/2045-9912.215752.
16. Viebahn-Hänsler R, Fernández OSL, Fahmy Z. Ozone in medicine: the low-dose ozone concept — guidelines and treatment strategies. Ozone: Science & Engineering. 2012. Vol. 34. P. 408-424.
17. Zanardi I, Borrelli E, Valacchi G, Travagli V, Bocci V. Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity. Curr Med Chem. 2016;23(4):304-14. DOI:10.2174/0929867323666151221150420
18. Di Mauro R, Cantarella G, Bernardini R, Di Rosa M,. Barbagallo I, et al. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int. J. Mol. Sci. 2019 Feb 1. 20(3). pii: E634. DOI: 10.3390/ijms20030634.
19. Bocci V, Zanardia I, Valacchi G, Borrelli E, Travagli V. Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):127-38. DOI: 10.2174/1871529x1502151209114642.
20. Masan J, Sramka M, Rabarova D. The possibilities of using the effects of ozonetherapy in neurology. Neuro Endocrinol Lett. 2021 Mar;42(1):13-21. PMID: 33932964. URL: https://europepmc.org/article/med/33932964.
21. Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Front Physiol. 2022 Feb 23;13:840623. DOI: 10.3389/fphys.2022.840623.
22. Serra MEG, Baeza-Noci J, Mendes Abdala CV, Luvisotto MM, Bertol CD, Anzolin AP. The role of ozone treatment as integrative medicine. An evidence and gap map. Front Public Health. 2023 Jan 16;10:1112296. DOI: 10.3389/fpubh.2022.1112296.
23. Wen Q, Liu D, Wang X, Zhang Y, Fang S, Qiu X, Chen Q. Int Wound J. 2022 May;19(4):853-870. DOI: 10.1111/iwj.13687.
Стаття надійшла до редакції 05.10.2023 р.
Received October, 5, 2023.